Oct 26 (Reuters) - Conmed Corp CNMD.N :
* ORATION ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS
* Q3 SALES ROSE 10.6 PERCENT TO $275.1 MILLION
* QTRLY DILUTED NET EARNINGS PER SHARE WERE $1.48
* QTRLY ADJUSTED DILUTED NET EARNINGS PER SHARE WERE $0.77
* COMPANY IS NARROWING ITS REVENUE GUIDANCE FOR FULL YEAR
2022 AND
NOW EXPECTS REVENUE BETWEEN $1.1 BILLION AND $1.115 BILLION
* COMPANY NOW EXPECTS FULL-YEAR 2022 ADJUSTED DILUTED NET
EARNINGS
PER SHARE IN RANGE OF $3.21 TO $3.28
* Q3 EARNINGS PER SHARE VIEW $0.75, REVENUE VIEW $280.8
MILLION --
REFINITIV IBES DATA
* FY2022 EARNINGS PER SHARE VIEW $3.28, REVENUE VIEW $1.11
BILLION
-- REFINITIV IBES DATA
Source text for Eikon: ID:nBw5J5qzsa
Further company coverage: CNMD.N
((Reuters.Briefs@thomsonreuters.com;))